{"SPADE_UN_16374": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16374", "Peptide Name": "LL-37 (17-29) [V21L]", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "FKRILQRIKDFLR", "Sequence Length": 13, "UniProt Entry": ["http://www.uniprot.org/uniprot/P49913"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:A549 (IC50=19.2 μg/ml)", "Hemolytic Activity": "Human erythrocytes:Not active up to 500 µg/ml", "Cytotoxicity": "DLF lung fibroblasts:IC50=76.8 μg/ml", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C81H137N25O17", "Mass": 1733.11, "PI": 11.72, "Net Charge": 4, "Hydrophobicity": -0.47, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents", "Pubmed ID": "32567085", "Reference": "J Pept Sci. 2020 Jul;26(7)e3254.", "Author": "Tzitzilis A, Boura-Theodorou A, Michail V, Papadopoulos S, Krikorian D, Lekka ME, Koukkou AI, Sakarellos-Daitsiotis M, Panou-Pomonis E.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=32567085"}], "Frequent Amino Acids": "RFI", "Absent Amino Acids": "ACEGHMNOPSTUVWY", "Basic Residues": 5, "Acidic Residues": 1, "Hydrophobic Residues": 6, "Polar Residues": 6, "Positive Residues": 5, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_04257", "Similarity": 1.0, "Sequence": "LLGDFFRKSKEKIGKEFKRI"}, {"SPADE_ID": "SPADE_N_10858", "Similarity": 1.0, "Sequence": "FRKSKEKIGKEFKRI"}, {"SPADE_ID": "SPADE_UN_05544", "Similarity": 1.0, "Sequence": "WRINIFKRI"}]}}}